Philippe Talaga
9Patents
3h-index
29Co-inventors
53Inventor score
Filing activity: Jul 6, 2004 → Sep 10, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11147864B2 | Multivalent pneumococcal polysaccharide-protein conjugate composition | Human Necessities | 4 | Active |
| US11123417B2 | Multivalent pneumococcal polysaccharide-protein conjugate composition | Chemistry; Metallurgy | 4 | Active |
| US8338137B2 | Type 5 and type 8 capsular polysaccharides of overproducing S. aureus strains | Human Necessities | 3 | Active |
| US11241489B2 | Multivalent pneumococcal polysaccharide-protein conjugate composition | Human Necessities | 3 | Active |
| US11224652B2 | Multivalent pneumococcal polysaccharide-protein conjugate composition | Human Necessities | 2 | Active |
| US7320874B2 | Assaying the teichoic acids of gram+ bacteria | Emerging Cross-Sectional Technologies | 0 | Expired |
| US11911452B2 | Multivalent pneumococcal polysaccharide-protein conjugate composition | Chemistry; Metallurgy | 0 | Active |
| US10772946B2 | Immunogenic compositions against S. aureus | Human Necessities | 0 | Active |
| US11554170B2 | Immunogenic formulations comprising linear or branched polyacrylic acid polymer adjuvants | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.